AstraZeneca May Market Unbranded Tamoxifen If Barr Contract Not Resumed
Nolvadex maker AstraZeneca may market its own tamoxifen generic if it cannot reach an agreement with Barr to reinstate the companies' supply and distribution agreement
Nolvadex maker AstraZeneca may market its own tamoxifen generic if it cannot reach an agreement with Barr to reinstate the companies' supply and distribution agreement